Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 10, 2007, Pages 1583-1593

  Capirci, Carlo ^a   Rampin, Lucia ^b   Erba, Paola A ^c   Galeotti, Fabrizio ^a   Crepaldi, Giorgio ^a   Banti, Elena ^b   Gava, Marcello ^a   Fanti, Stefano ^d   Mariani, Giuliano ^c   Muzzio, Pier Carlo ^e   Rubello, Domenico ^e  

^a S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Chemo radiation; Pathological response; PET CT; Rectal cancer

Indexed keywords

CAPECITABINE; FLUORODEOXYGLUCOSE; FLUOROURACIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PATIENT SATISFACTION; PREDICTION; PROGNOSIS; RECTUM CANCER; RELIABILITY; SEQUENTIAL ANALYSIS; TREATMENT RESPONSE; TUMOR REGRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34748814336     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0426-1     Document Type: Article

References (40)

1. Valentini V, Coco C, Cellini N. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer. Acute toxicity, tumor response and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001;51:371-83.
2. Mohiuddin M, Hayne M, Regine WF. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiotherapy in advanced/recurrent rectal cancer. Int J Radiat Oncol Biol Phys 2000;48:1025-80.
3. Calvo FA, Cantalapiedra R, Gòmez-Espì M. Ano-rectal sphincter preservation following preoperative chemoradiation in cT3-4Nx rectal cancer. Influence of tumor distance and downstaging. Rev Oncologia 1998;206:755-60.
4. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119-24.
5. Hoffmann KT, Rau B, Wust P. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 2002;178:386-92.
6. Rau B, Huenerbein M, Barth C. Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endsc 1999;13:980-4.
7. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiation theraphy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-6.
8. Vecchio FM, Valentini V, Minsky BD. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752-60.
9. Kubota K. From tumor biology to clinical PET: a review of position emission tomography (PET) in oncology. Ann Nucl Med 2001;15:471-86.
10. Haberkorn IJ, Strauas LG, Dimitracopoulou A. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumours receiving radiotherapy. J Nucl Med 1991;32:1485-90.
11. Capirci C, Valvo F, Salviato S. Concurrent boost radiotherapy as preoperative treatment for locally advanced rectal carcinoma: a new beam arrangement. Tumori 2002;88:325-30.
12. Capirci C, Polico C, Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using the new "Up Down Table" device. Int J Radiat Oncol Biol Phys 2002;88:325-30.
13. Miller AB. Reporting result of cancer treatment. Cancer 1981;47:207-14.
14. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3:127-31.
15. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996;348:1605-10.
16. Mohiuddin M, Regine WF, Marks J, aMarks JW. High-dose preoperative radiation and the challenge of a sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys 1998;40:569-74.
17. Sauer R. Adjuvant versus neo-adjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 2003;40:57-S124-5.
18. Kaminsky-Forret MC, Conroy T, Luporosi E. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;5:935-41.
19. Ahmad NR, Nagle DA, Topham A. Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1997;39:284.
20. Berger C, De Muret A, Garaud P. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-27.
21. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colrectal Dis 1997;12:19-23.
22. Oku S, Nakagawa K, Momose T. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Ann Nucl Med 2002;16:409-16.
23. Calvo FA, Domper M, Matute R. 18FDG Positron Emission Tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528-35.
24. 18F]FDG PET in patients with locally advanced rectal cancer treated with neo-adjuvant radiochemotherapy. Am J Roengtenol 2006;187:W202-8.
25. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta analysis. Radiology 2004;232:773-83.
26. Kwk H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colrectal Disease 2000;15:9-20.
27. Kim YH, Kim DY, Kim TH. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with respectable rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:761-8.
28. Delrio P, Lastoria S, Avallone A. Early evaluation using PET-FDG of the efficiency of neo-adjuvant radiochemotherapy treatment in locally advanced neoplasia of the lower rectum. Tumori 2003;89:50-3.
29. 18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eu J Cancer 1999;35:1773-82.
30. Chessin BD, Akhurst T, Yeung H. Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response: A prospective analysis. ASCO 2005;Abs. 3612.
31. Guillem JG, Moore T, Akhurst T. Sequential FDG-PET imaging for detecting subclinical rectal Cencer response to preoperative combined modality therapy. J Am Coll Surg 2004;199:1-7.
32. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Mandoliti G, Polico C. Restaging after neo-adjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacol 2004;58;451-7.
33. Deneke T, Rau B, Hoffmann KT. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol 2005;15:1658-66.
34. Amthauer H, Deneke T, Rau B. Response prediction by FDG-PET after neo-adjuvant radiochemotherapy and combined hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 2004;31:811-9.
35. Fokunaga T, Okazomi S, Kolde Y, Isono K, Imazckl K. Evaluation of esophageal cancer using fluorine-18-fluorodeoxyglucose PET. J Nucl Med 1988;39:1002-7.
36. Minn H, Lapela M, Klemi PJ. Prediction survival with fluorine-18- fluorodeoxyglucose PET in head and neck cancer. J Nucl Med 1997;38:1907-11.
37. Guillem JG, Puig-La Calle J, Akhurst T. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-Fluorodeoxyglucose Positron Emission Tomography. Dis Colon Rectum 2000;43:18-24.
38. Di Fabio F, Pinto C, Ceccarelli C. Correlation between FDG-PET and pathologic response in patients with rectal cancer treated with neo-adjuvant chemo-radiotehrapy: First results of the Bologna Project. ASCO 2005;Abs. n. 3623.
39. Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, et al. 18F-FDG PET i san early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advancer rectal cancer. J Nucl Med 2006;47:1241-8.
40. 11C]methyl-L-methionine for therapy monitoring in patients with rectal cancer. Eur J Nucl Med Mol Imaging 2002;29:789-96.